Newtyn Management, LLC - Q1 2024 holdings

$502 Million is the total value of Newtyn Management, LLC's 40 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 37.5% .

 Value Shares↓ Weighting
IAC BuyIAC INC$75,902,820
+19.7%
1,423,000
+17.5%
15.12%
+21.5%
PAR BuyPAR TECHNOLOGY CORP$56,558,704
+7.5%
1,246,885
+3.2%
11.27%
+9.1%
CNNE SellCANNAE HLDGS INC$47,037,600
-29.7%
2,115,000
-38.3%
9.37%
-28.7%
VTOL BuyBRISTOW GROUP INC$29,212,800
+19.7%
1,074,000
+24.4%
5.82%
+21.5%
MACK  MERRIMACK PHARMACEUTICALS IN$27,674,460
+10.1%
1,873,6940.0%5.51%
+11.8%
AIV BuyAPARTMENT INVT & MGMT COcl a$24,570,000
+85.7%
3,000,000
+77.6%
4.89%
+88.4%
CCOI NewCOGENT COMMUNICATIONS HLDGS$24,498,750375,000
+100.0%
4.88%
SPB  SPECTRUM BRANDS HLDGS INC NE$22,246,892
+11.6%
249,9370.0%4.43%
+13.2%
CIO BuyCITY OFFICE REIT INC$19,995,980
+2.2%
3,838,000
+19.8%
3.98%
+3.7%
OFIX BuyORTHOFIX MED INC$18,461,788
+30.0%
1,271,473
+20.7%
3.68%
+31.9%
MITK BuyMITEK SYS INC$16,335,738
+26.2%
1,158,563
+16.7%
3.25%
+28.1%
TBPH SellTHERAVANCE BIOPHARMA INC$14,746,052
-31.0%
1,643,930
-13.5%
2.94%
-29.9%
MBI  MBIA INC$12,675,000
+10.5%
1,875,0000.0%2.52%
+12.1%
CLFD NewCLEARFIELD INC$12,336,000400,000
+100.0%
2.46%
GLPG BuyGALAPAGOS NVspon adr$11,785,200
+32.9%
366,000
+67.8%
2.35%
+34.9%
CDMO NewAVID BIOSERVICES INC$10,050,0001,500,000
+100.0%
2.00%
NODK BuyNI HLDGS INC$9,167,386
+32.9%
605,108
+14.0%
1.83%
+34.9%
SellBV FINL INC$9,002,027
-36.5%
871,445
-12.9%
1.79%
-35.6%
BuySTAR HLDGS$6,168,938
-7.6%
477,472
+7.2%
1.23%
-6.2%
 FORUM ENERGY TECHNOLOGIES INnote 9.000% 8/0$5,482,731
+1.2%
5,483,8720.0%1.09%
+2.6%
NewFIDELITY WISE ORIGIN BITCOIN$5,399,22087,000
+100.0%
1.08%
KOD SellKODIAK SCIENCES INC$5,260,000
-2.3%
1,000,000
-43.5%
1.05%
-0.9%
 ALGOMA STL GROUP INC$5,016,733
-15.4%
590,8990.0%1.00%
-14.1%
PCG  PG&E CORP$4,507,116
-7.0%
268,9210.0%0.90%
-5.7%
FET  FORUM ENERGY TECHNOLOGIES IN$3,882,114
-9.9%
194,3000.0%0.77%
-8.6%
WVE SellWAVE LIFE SCIENCES LTD$3,085,000
+19.8%
500,000
-2.0%
0.62%
+21.5%
ETNB Sell89BIO INC$2,910,000
-4.4%
250,000
-8.3%
0.58%
-3.0%
BuyMURAL ONCOLOGY PUB LTD CO$2,445,000
-7.2%
500,000
+12.4%
0.49%
-5.8%
BOLT BuyBOLT BIOTHERAPEUTICS INC$2,380,000
+36.8%
1,700,000
+9.4%
0.47%
+38.6%
ADPT BuyADAPTIVE BIOTECHNOLOGIES COR$2,002,045
+26.9%
623,690
+93.7%
0.40%
+28.7%
PHAT SellPHATHOM PHARMACEUTICALS INC$1,752,300
-70.3%
165,000
-74.5%
0.35%
-69.9%
OLMA  OLEMA PHARMACEUTICALS INC$1,698,000
-19.3%
150,0000.0%0.34%
-18.2%
AVIR SellATEA PHARMACEUTICALS INC$1,616,000
+4.2%
400,000
-21.3%
0.32%
+5.9%
AVRO SellAVROBIO INC$1,432,182
-61.5%
1,118,892
-59.1%
0.28%
-61.0%
VNDA BuyVANDA PHARMACEUTICALS INC$1,278,210
+4.4%
311,000
+7.2%
0.26%
+6.2%
ALGS SellALIGOS THERAPEUTICS INC$1,176,000
+41.1%
1,200,000
-4.4%
0.23%
+42.7%
SNSE SellSENSEI BIOTHERAPEUTICS INC$976,741
-10.2%
930,230
-40.8%
0.20%
-8.9%
NewADVERUM BIOTECHNOLOGIES INC$653,11246,189
+100.0%
0.13%
BDTX SellBLACK DIAMOND THERAPEUTICS I$633,750
-19.5%
125,000
-55.4%
0.13%
-18.2%
 LEAFLY HOLDINGS INC*w exp 02/04/202$19,039
+91.1%
634,6400.0%0.00%
+100.0%
VHAQRT ExitVIVEON HEALTH ACQUISITION COright 12/31/2025$0-250,000
-100.0%
-0.00%
ExitARISZ ACQUISITION CORPright 99/99/9999$0-250,000
-100.0%
-0.01%
ExitNUKKLEUS INC$0-26,990
-100.0%
-0.02%
ABIO ExitARCA BIOPHARMA INC$0-269,320
-100.0%
-0.09%
TLYS ExitTILLYS INCcl a$0-62,784
-100.0%
-0.09%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-823,096
-100.0%
-0.12%
ExitNB BANCORP INC$0-46,945
-100.0%
-0.12%
FIXX ExitHOMOLOGY MEDICINES INC$0-1,399,260
-100.0%
-0.17%
CYT ExitCYTEIR THERAPEUTICS INC$0-3,021,500
-100.0%
-1.80%
ExitARDAGH METAL PACKAGING S A$0-2,464,881
-100.0%
-1.86%
GTX ExitGARRETT MOTION INC$0-1,029,523
-100.0%
-1.95%
MDRX ExitVERADIGM INC$0-1,461,692
-100.0%
-3.01%
GIII ExitG III APPAREL GROUP LTD$0-760,207
-100.0%
-5.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC30Q2 20242.9%
PG&E CORP27Q2 202419.2%
MERRIMACK PHARMACEUTICALS IN27Q1 20245.7%
ADIENT PLC26Q1 202317.3%
SPECTRUM BRANDS HLDGS INC NE24Q2 20246.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC17Q2 20246.8%
FORUM ENERGY TECHNOLOGIES IN16Q2 20243.5%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q1 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Veradigm Inc.March 08, 202410,500,0009.6%
Sensei Biotherapeutics, Inc.March 07, 2024554,4932.2%
AVROBIO, Inc.February 14, 20242,734,1756.1%
BV Financial, Inc.February 14, 20241,000,0008.8%
City Office REIT, Inc.February 14, 20243,203,2428.0%
Cyteir Therapeutics, Inc.February 14, 20243,021,5008.4%
PACIFIC GAS & ELECTRIC CoSold outFebruary 14, 202400.0%
MERRIMACK PHARMACEUTICALS INCJanuary 25, 20241,873,69413.1%
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
SC 13G2024-08-16
13F-HR2024-08-14
13F-HR2024-05-15
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View Newtyn Management, LLC's complete filings history.

Compare quarters

Export Newtyn Management, LLC's holdings